Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model

FASEB J. 2019 Mar;33(3):4141-4153. doi: 10.1096/fj.201801146RR. Epub 2018 Nov 28.

Abstract

The aim of this study was to evaluate whether damage to the neurovascular unit in diabetes depends on reactive metabolites such as methylglyoxal (MG), and to assess its impact on retinal gene expression. Male Wistar rats were supplied with MG (50 mM) by drinking water and compared with age-matched streptozotocin-diabetic animals and untreated controls. Retinal damage was evaluated for the accumulation of MG-derived advanced glycation end products, changes in hexosamine and PKC pathway activation, microglial activation, vascular alterations (pericyte loss and vasoregression), neuroretinal function assessed by electroretinogram, and neurodegeneration. Retinal gene regulation was studied by microarray analysis, and transcription factor involvement was identified by upstream regulator analysis. Systemic application of MG by drinking water increased retinal MG to levels comparable with diabetic animals. Elevated retinal MG resulted in MG-derived hydroimidazolone modifications in the ganglion cell layer, inner nuclear layer, and outer nuclear layer, a moderate activation of the hexosamine pathway, a pan-retinal activation of microglia, loss of pericytes, increased formation of acellular capillaries, decreased function of bipolar cells, and increased expression of the crystallin gene family. MG mimics important aspects of diabetic retinopathy and plays a pathogenic role in microglial activation, vascular damage, and neuroretinal dysfunction. In response to MG, the retina induces expression of neuroprotective crystallins.-Schlotterer, A., Kolibabka, M., Lin, J., Acunman, K., Dietrich, N., Sticht, C., Fleming, T., Nawroth, P., Hammes, H.-P. Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model.

Keywords: animal; glycation/AGE; retina.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capillaries / drug effects
  • Capillaries / metabolism
  • Capillaries / physiopathology
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / physiopathology
  • Diabetic Retinopathy / chemically induced*
  • Diabetic Retinopathy / etiology
  • Diabetic Retinopathy / metabolism
  • Diabetic Retinopathy / physiopathology
  • Disease Models, Animal
  • Glycation End Products, Advanced / metabolism
  • Hyperglycemia / metabolism
  • Hyperglycemia / physiopathology*
  • Male
  • Microglia / drug effects
  • Microglia / metabolism
  • Microglia / physiology
  • Pericytes / drug effects
  • Pericytes / metabolism
  • Pericytes / physiology
  • Pyruvaldehyde / metabolism
  • Pyruvaldehyde / pharmacology*
  • Rats
  • Rats, Wistar
  • Retina / drug effects*
  • Retina / metabolism
  • Retina / physiopathology
  • Retinal Vessels / drug effects
  • Retinal Vessels / metabolism
  • Retinal Vessels / physiopathology
  • Streptozocin / pharmacology

Substances

  • Glycation End Products, Advanced
  • Streptozocin
  • Pyruvaldehyde